drugset / Trial / NCT00002308
A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
Completed
Bristol-Myers Squibb
RandomizedSingle-groupDouble-blindTreatment
Summary
To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 1991-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stavudine | Other / unclassified | — | — |